Signaling pathways leading to the activation of IKK and MAPK by thymosin alpha1.
Peng. Xiao X; Zhang. Ping P; Wang. Xin X; Chan. Justin J; Zhu. Mingwei M; Jiang. Meisheng M; Tuthill. Cynthia C; Wan. Yinsheng Y; Dragoi. Ana Maria AM; Chu. Wen-Ming WM
Key Findings
- TĪ±1 triggers ILā6, ILā10 and ILā12 release in mouse macrophages via IKK and MAPK signaling
- TRAF6 is required for JNK activation while IRAK4 is needed for IKK and PKCĪ¶ activation
- Inhibiting p38 kinase diminishes ILā6 production in response to TĪ±1
Practical Outcomes
- For DIY health enthusiasts, this work confirms that TĪ±1 can stimulate immune signaling, which may be useful for immune support strategies. However, the effects depend on complex cellular pathways, so simple dosage tweaks are unlikely to change outcomes dramatically. Any attempts to combine TĪ±1 with other agents (e.g., p38 inhibitors) should be approached cautiously and only after more human data are available.
Summary
Thymosināalphaā1 (TĪ±1) activates immune cells called macrophages, causing them to release signaling proteins (ILā6, ILā10, ILā12) through specific internal pathways (IKK and MAPK). The study shows that certain molecules (TRAF6, IRAK4, PKCĪ¶) are needed for this activation, and blocking the p38 part of the pathway reduces ILā6 production.
Abstract
Thymosin alpha 1 (Talpha1) has therapeutic potential in the treatment of infectious diseases and cancer. However, the exact molecular pathways for Talpha1 action are not fully understood. We found that Talpha1 induces the production of interleukin-6 (IL-6), IL-10, and IL-12 in murine bone marrow-derived macrophages (BMDMs) through IKK and MAPK pathways. Talpha1 triggers the activation of AP-1 and the phosphorylation of JNK and p38. Inhibition of p38 impairs IL-6 production in response to Talpha1. Further, TRAF6 is involved in the activation of JNK and IRAK4 is involved for the activation of IKK and PKCzeta in a Talpha1-induced system. Loss of IRAK4 largely blocked induction of IL-6. Thus, our studies define early signal events that are critical for the Talpha1-induced immune responses.
Study Information
pubmed
2007
2007-06-13T00:00:00.000Z
10.1196/annals.1415.025
20
35